PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Pavelic AR. Cells. Dec 2022; 12(1) Pubmed [13501]
Pawar PS. Am J Geriatr Pharmacother. Dec 2010; 8(6): 595-8 Pubmed [521]
Pawlowska M. Eur J Clin Pharmacol. Jun 2015; 71(6): 699-705 Pubmed [8046]
Pea F. Ann Pharmacother. Nov 2008; 42(11): 1711-6 Pubmed [5919]
Pea F. Antivir Ther. Jan 2008; 13(5): 739-42 Pubmed [7062]
Pea F. Clin Pharmacokinet. Jan 2001; 40(11): 833-68 Pubmed [7511]
Pea F. Transpl Infect Dis. Dec 2015; 17(6): 926-8 Pubmed [7017]
Peacock LE. Age Ageing. Jul 2011; 40(4): 528 Pubmed [3292]
Peano C. Ann Emerg Med. Nov 1997; 30(5): 704-8 Pubmed [2626]
Pearce RE. Drug Metab Dispos. Jun 2006; 34(6): 1035-40 Pubmed [4726]
Pearce RE. Drug Metab Dispos. Nov 2002; 30(11): 1170-9 Pubmed [74]
Pearce RE. Drug Metab Dispos. Sep 2013; 41(9): 1686-94 Pubmed, Volltext, DOI [5299]
Pecikoza U. Psychopharmacology (Berl). May 2020; 237(5): 1435-1446 Pubmed [11957]
Pecora Fulco P. Ann Pharmacother. Nov 2018; 52(11): 1165-1166 Pubmed [6669]
Pecora Fulco P. Ann Pharmacother. Sep 2003; 37(9): 1325-8 Pubmed [6709]
Pedersen JK. Ugeskr Laeger. Sep 2016; 178(39) Pubmed [5917]
Pedersen KE. Acta Med Scand. Jan 1985; 218(2): 229-32 Pubmed [382]
Pedersen OL. Eur J Clin Pharmacol. Jan 1982; 23(6): 513-21 Pubmed [3321]
Pedraz-Petrozzi B. Clin Case Rep. Mar 2023; 11(3): e7045 Pubmed [12980]
Pedroso JL. Neurologist. Mar 2011; 17(2): 89-90 Pubmed [10587]
Peet CF. Eur J Drug Metab Pharmacokinet. Oct 2005; 30(4): 275-86 Pubmed [7985]
Peet M, Middlemiss DN, Yates RA. Pharmacocinetic interaction between propanolol and chlorpromazine in schizophrenic patients. Lancet (1980) ii, 978 [923]
Peet M, Middlemiss DN, Yates RA. Propanolol in schizophrenia II. Clinical and biochemical aspects of combining propanolol with chlorpromazine. Br J Psychiatry (1081) 138, 112-7 [924]
Peet M. Drug Saf. Feb 1995; 12(2): 146-53 Pubmed [8962]
Peeters M. Ann Pharmacother. Jun 2008; 42(6): 757-65 Pubmed [8455]
Peihua L. Open Med (Wars). Jul 2018; 13: 270-277 Pubmed, Volltext, DOI [10441]
Peitz GJ. South Med J. Apr 2009; 102(4): 411-2 Pubmed [9537]
Pejčić AV. Int J Psychiatry Clin Pract. Mar 2022; 26(1): 29-42 Pubmed [12398]
Pelet A. Am J Drug Alcohol Abuse. Jul 2011; 37(4): 264-8 Pubmed [6307]
Pelkonen O. Arch Toxicol. Oct 2008; 82(10): 667-715 Pubmed [3716]
Pelkonen O. Toxicology. Apr 2000; 144(1-3): 139-47 Pubmed [4422]
Pellene A. Clin Neuropharmacol. Nov 2015; 38(6): 252-4 Pubmed [10394]
Pelton GH. Contemp Clin Trials. Mar 2014; 37(2): 200-8 Pubmed [13119]
Pelton GH. Int J Geriatr Psychiatry. Jun 2016; 31(6): 648-55 Pubmed [9951]
Peltoniemi MA. Clin Pharmacokinet. Sep 2016; 55(9): 1059-77 Pubmed [5159]
Peltoniemi MA. Eur J Clin Pharmacol. Jun 2012; 68(6): 979-86 Pubmed [3709]
Peña E. Brain Sci. Feb 2021; 11(2) Pubmed [12227]
Pence BW. AIDS Behav. Jun 2014; 18(6): 1142-51 Pubmed, Volltext, Springer [3808]
Peng B. Clin Pharmacokinet. Jan 2005; 44(9): 879-94 Pubmed [4899]
Pennachio D.L. Patient Care. Oct 2000; 34(19) Pubmed [11617]
Penning-van Beest FJ. J Thromb Haemost. Feb 2008; 6(2): 284-90 Pubmed [9384]
Penninga EI. Basic Clin Pharmacol Toxicol. Jan 2016; 118(1): 37-44 Pubmed [5097]
Pentikäinen PJ et al. Acta Pharmacol Toxicol (1986) 59 (Suppl 5), 91 [2140]
Penttilå O. Br Med J. Jun 1974; 2(5917): 470-2 Pubmed, Volltext [5626]
Penzak et al. J Clin Psychopharmacol 2002;2(4):366-370 [3009]
Penzak SR. Am J Cardiovasc Drugs. Jan 2002; 2(2): 91-106 Pubmed [6901]
Penzak SR. J Acquir Immune Defic Syndr. Dec 2005; 40(5): 573-80 Pubmed [6476]
Penzak SR. Ther Drug Monit. Jun 2004; 26(3): 322-30 Pubmed [6416]
Penzner JB. J Child Adolesc Psychopharmacol. Oct 2009; 19(5): 563-73 Pubmed, Volltext, DOI [3280]
Perazella MA. Am J Med Sci. Jun 2003; 325(6): 349-62 Pubmed [5695]
Perdix (Moexipril), Schwarz Pharma Ltd. Summary of product characteristics, March 2000 [1734]
Pereira BB. J Toxicol Environ Health B Crit Rev. Apr 2020; : 1-5 Pubmed [8904]
Pereira MA. Rev Bras Anestesiol. Jan 1972; 22(1): 10-9 Pubmed [10000]
Peremans K. Nucl Med Commun. Aug 2008; 29(8): 724-9 Pubmed [4789]
Perez Jimenez TE. Drug Metab Dispos. Oct 2016 Pubmed, Volltext, DOI [4332]
Perez Ruixo JJ. J Clin Pharmacol. Mar 2015; 55 Suppl 3: S85-92 Pubmed [4017]
Perez-Lloret S. CNS Drugs. Aug 2016; 30(8): 703-17 Pubmed [10439]
Pérez-Torre P. Neurologia (Engl Ed). Sep 2021 Pubmed [12181]
Pergolizzi J. Pain Pract. Jul 2008; 8(4): 287-313 Pubmed [8991]
Pericàs JM. Clin Microbiol Infect. Jun 2018; 24(6): 673-676 Pubmed [8121]
Periclou A. Eur J Drug Metab Pharmacokinet. Jan 2021; 46(1): 53-69 Pubmed [11179]
Periclou A. J Clin Pharmacol. Apr 2010; 50(4): 422-33 Pubmed [3556]
Peritogiannis et al. (2007) J Clin Psychopharmacol 27(2):235-238 [2964]
Peritogiannis et al. Schizophr Res. 2005 Nov 15;79(2-3):345-6 [1471]
Peritogiannis V. Gen Hosp Psychiatry. May 2007; 29(3): 281-2 Pubmed [6237]
Peritogiannis V. Schizophr Res. Nov 2005; 79(2-3): 345-6 Pubmed [8963]
Perlemuter G. CNS Drugs. Sep 2016; 30(9): 877-88 Pubmed [4990]
Perlman BB. Lancet. Feb 1990; 335(8686): 416 Pubmed [1721]
Perloff ES. Drug Metab Dispos. Jun 2005; 33(6): 764-70 Pubmed [6301]
Perloff MD. J Pharm Sci. Nov 2001; 90(11): 1829-37 Pubmed [7974]
Perloff MD. Xenobiotica. Feb 2004; 34(2): 133-50 Pubmed [9705]
Perry CM. Drugs. Jul 1997; 54(1): 81-7; discussion 88 Pubmed [11950]
Perry LA. Cochrane Database Syst Rev. May 2018; 5: CD011943 Pubmed, Volltext, DOI [9871]
Perry ME. Int J STD AIDS. Aug 2013; 24(8): 639-42 Pubmed [7041]
Perry NK. Postgrad Med J. Apr 2000; 76(894): 254-6 Pubmed, Volltext, DOI [3270]
Perry PJ. J Clin Psychopharmacol. Feb 1993; 13(1): 46-51 Pubmed [1552]
Perse TL. Am J Psychiatry. Dec 1987; 144(12): 1543-8 Pubmed [12920]
Person, Siwers. Swed Dent J (1975) 68, 9-18 [1946]
Persson CG. Life Sci. Mar 1986; 38(12): 1057-72 Pubmed [6938]
Persson MP. Clin Pharmacol Ther. Mar 1988; 43(3): 324-31 Pubmed [1852]
Pertz HH. Planta Med. Jul 2011; 77(10): 973-8 Pubmed [12324]
Perucca Br J Clin Pharmacol 2005; 61:246-255 [2063]
Perucca E. Br J Clin Pharmacol. Aug 1977; 4(4): 485-6 Pubmed, Volltext [1596]
Perucca E. Br J Clin Pharmacol. Mar 2006; 61(3): 246-55 Pubmed, Volltext, DOI [427]
Perucca E. Clin Pharmacokinet. Jan 1982; 7(1): 57-84 Pubmed [9296]
Perucca E. Clin Pharmacokinet. Jul 1996; 31(1): 29-46 Pubmed [9350]
Perucca E. Clin Pharmacol Ther. Nov 1994; 56(5): 471-6 Pubmed [1473]
Perucca E. Epilepsia. Jan 1999; 40 Suppl 9: S7-13 Pubmed [9416]
Perucca E. Epilepsia. Jul 2008; 49(7): 1123-41 Pubmed [470]
Perucca E. Epilepsy Res. Feb 2003; 53(1-2): 47-56 Pubmed [9331]
Perucca Emilio, Johannessen Svein I, Treatment of Epilepsy: Focus on Levetiracetam. The ideal pharmacokinetic properties of an antiepileptic drug: how close does Ievetiracetam come? Epileptic Disord 2003; 5 (Supp/ 7): S17-S26 [2562]
Perugi G. Pharmacopsychiatry. Jul 2001; 34(4): 137-41 Pubmed [10387]
Pesavento TE. J Am Soc Nephrol. Jun 1996; 7(6): 831-5 Pubmed [4272]
Pescovitz MD. Am J Transplant. Oct 2009; 9(10): 2324-30 Pubmed [12742]
Pessanha TM. AIDS. Feb 2007; 21(4): 529-32 Pubmed [6388]
Peter JV. Med J Aust. Aug 2006; 185(4): 223-5 Pubmed [6513]
Peter Overbeck. Duale RAS-Blockade Nutzen plus Nutzen ergibt keinen Nutzen. ÄrzteZeitung. Stand Oct 2019. https://www.aerztezeitung.de/medizin/krankheiten/herzkreislauf/herzinsuffizienz/article/834825/duale-ras-blockade-nutzen-plus-nutzen-ergibt-keinen-nutzen.html [8091]
Peters DH. Drugs. May 1993; 45(5): 760-87 Pubmed [9415]
Peters O. J Nutr Health Aging. Jan 2012; 16(6): 544-8 Pubmed [9944]
Peters U. Dtsch Med Wochenschr. Nov 1974; 99(47): 2381-6 Pubmed [6193]